Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease.

Literature DB >> 11138324

Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease.

M Cutolo, R H Straub.

Abstract

Entities: Disease

Mesh：

Year: 2000 PMID： 11138324

Source DB: PubMed Journal: Clin Exp Rheumatol ISSN： 0392-856X Impact factor: 4.473

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.

Authors: K Larsson; D Mellström; E Nordborg; C Nordborg; A Odén; E Nordborg
Journal: Ann Rheum Dis Date: 2005-08-26 Impact factor: 19.103

Review 2. Psychoneuroimmunology-developments in stress research.

Authors: Rainer H Straub; Maurizio Cutolo
Journal: Wien Med Wochenschr Date: 2017-06-09

3. Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.

Authors: Ombretta Viapiana; Davide Gatti; Sonila Troplini; Silvano Adami; Elena Fracassi; Luca Idolazzi; Maurizio Rossini
Journal: Rheumatol Int Date: 2014-08-23 Impact factor: 2.631

4. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.

Authors: M Cutolo; C M Montecucco; L Cavagna; R Caporali; S Capellino; P Montagna; L Fazzuoli; B Villaggio; B Seriolo; A Sulli
Journal: Ann Rheum Dis Date: 2006-04-27 Impact factor: 19.103

5. A case of apoplectic lymphocytic hypophysitis complicated by polymyalgia rheumatica.

Authors: Yasuko Tanaka; Tomohito Hirao; Keisuke Tsutsumi; Taiichiro Miyashita; Yasumori Izumi; Yumi Mihara; Masahiro Ito; Hiroshi Baba; Kiysohi Migita
Journal: Rheumatol Int Date: 2010-06-01 Impact factor: 2.631

6. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica: can we just move a step forward? Comments on "Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis".

Authors: Ciro Manzo
Journal: Clin Rheumatol Date: 2021-08-30 Impact factor: 2.980

Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease.

1. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis.

Review 2. Psychoneuroimmunology-developments in stress research.

3. Prednisone compared to methylprednisolone in the polymyalgia rheumatica treatment.

4. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.

5. A case of apoplectic lymphocytic hypophysitis complicated by polymyalgia rheumatica.

7. Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever.

8. Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis.

9. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis.

Review 10. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.